Strain identifier
BacDive ID: 10471
Type strain:
Species: Neisseria gonorrhoeae
Strain Designation: 89-018314, F-18, P935
Strain history: CIP <- 2001, CCM <- C. Thornsberry: strain F-18 <- J.E. Martin
NCBI tax ID(s): 485 (species)
General
@ref: 3508
BacDive-ID: 10471
DSM-Number: 9189
keywords: genome sequence, 16S sequence, Bacteria, microaerophile, mesophilic, Gram-negative
description: Neisseria gonorrhoeae 89-018314 is a microaerophile, mesophilic, Gram-negative bacterium of the family Neisseriaceae.
NCBI tax id
- NCBI tax id: 485
- Matching level: species
strain history
@ref | history |
---|---|
3508 | <- ATCC; ATCC 49226 <- C. Thornsberry; F-18 <- J. Martin; CDC 10.001 |
119706 | CIP <- 2001, CCM <- C. Thornsberry: strain F-18 <- J.E. Martin |
doi: 10.13145/bacdive10471.20230509.8.1
Name and taxonomic classification
LPSN
- @ref: 20215
- description: domain/bacteria
- keyword: phylum/pseudomonadota
- domain: Bacteria
- phylum: Pseudomonadota
- class: Betaproteobacteria
- order: Neisseriales
- family: Neisseriaceae
- genus: Neisseria
- species: Neisseria gonorrhoeae
- full scientific name: Neisseria gonorrhoeae (Zopf 1885) Trevisan 1885 (Approved Lists 1980)
synonyms
- @ref: 20215
- synonym: Merismopedia gonorrhoeae
@ref: 3508
domain: Bacteria
phylum: Proteobacteria
class: Betaproteobacteria
order: Neisseriales
family: Neisseriaceae
genus: Neisseria
species: Neisseria gonorrhoeae
full scientific name: Neisseria gonorrhoeae (Zopf 1885) Trevisan 1885
strain designation: 89-018314, F-18, P935
type strain: no
Morphology
cell morphology
@ref | gram stain | confidence | cell shape | motility |
---|---|---|---|---|
69480 | negative | 99.99 | ||
119706 | negative | coccus-shaped | no |
colony morphology
@ref | type of hemolysis | incubation period |
---|---|---|
3508 | gamma | 1-2 days |
119706 |
Culture and growth conditions
culture medium
@ref | name | growth | link | composition |
---|---|---|---|---|
3508 | COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) | yes | https://mediadive.dsmz.de/medium/693 | Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base |
36023 | MEDIUM 10 - Chocolate medium for Actinobacillus pleuropneumoniae, Capnocytophaga cynodegmi, Haemophilus and Neisseria | yes | Distilled water make up to (1000.000 ml);Columbia agar (39.000 g);Horseblood (100.000 ml);PolyVitex mischung (10.000 ml) | |
119706 | CIP Medium 10 | yes | https://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=10 |
culture temp
@ref | growth | type | temperature | range |
---|---|---|---|---|
3508 | positive | growth | 37 | mesophilic |
36023 | positive | growth | 37 | mesophilic |
48390 | positive | growth | 36 | mesophilic |
119706 | positive | growth | 25-37 | mesophilic |
119706 | no | growth | 41 | thermophilic |
Physiology and metabolism
oxygen tolerance
@ref | oxygen tolerance |
---|---|
3508 | microaerophile |
48390 | microaerophile |
spore formation
@ref | spore formation | confidence |
---|---|---|
69481 | no | 100 |
69480 | no | 100 |
metabolite utilization
@ref | Chebi-ID | metabolite | utilization activity | kind of utilization tested |
---|---|---|---|---|
119706 | 606565 | hippurate | - | hydrolysis |
119706 | 17632 | nitrate | - | builds gas from |
119706 | 17632 | nitrate | - | reduction |
119706 | 16301 | nitrite | - | builds gas from |
119706 | 16301 | nitrite | - | reduction |
68377 | 17306 | maltose | - | builds acid from |
68377 | 17992 | sucrose | - | builds acid from |
68377 | 18257 | ornithine | - | degradation |
68377 | 16199 | urea | - | hydrolysis |
68377 | 27897 | tryptophan | - | energy source |
metabolite production
@ref | Chebi-ID | metabolite | production |
---|---|---|---|
68377 | 35581 | indole | no |
119706 | 35581 | indole | no |
metabolite tests
- @ref: 68377
- Chebi-ID: 35581
- metabolite: indole
- indole test: -
enzymes
@ref | value | activity | ec |
---|---|---|---|
3508 | catalase | + | 1.11.1.6 |
3508 | cytochrome-c oxidase | + | 1.9.3.1 |
68377 | tryptophan deaminase | - | 4.1.99.1 |
68377 | alkaline phosphatase | - | 3.1.3.1 |
68377 | lipase | - | |
68377 | urease | - | 3.5.1.5 |
68377 | ornithine decarboxylase | - | 4.1.1.17 |
119706 | oxidase | + | |
119706 | beta-galactosidase | + | 3.2.1.23 |
119706 | alcohol dehydrogenase | - | 1.1.1.1 |
119706 | gelatinase | - | |
119706 | amylase | - | |
119706 | DNase | - | |
119706 | caseinase | - | 3.4.21.50 |
119706 | catalase | + | 1.11.1.6 |
119706 | tween esterase | - | |
119706 | gamma-glutamyltransferase | - | 2.3.2.2 |
119706 | lecithinase | - | |
119706 | lipase | - | |
119706 | lysine decarboxylase | - | 4.1.1.18 |
119706 | ornithine decarboxylase | - | 4.1.1.17 |
119706 | protease | - | |
119706 | urease | - | 3.5.1.5 |
68382 | alkaline phosphatase | - | 3.1.3.1 |
68382 | esterase (C 4) | + | |
68382 | esterase lipase (C 8) | + | |
68382 | lipase (C 14) | - | |
68382 | leucine arylamidase | + | 3.4.11.1 |
68382 | valine arylamidase | - | |
68382 | cystine arylamidase | - | 3.4.11.3 |
68382 | trypsin | - | 3.4.21.4 |
68382 | alpha-chymotrypsin | - | 3.4.21.1 |
68382 | acid phosphatase | + | 3.1.3.2 |
68382 | naphthol-AS-BI-phosphohydrolase | - | |
68382 | alpha-galactosidase | - | 3.2.1.22 |
68382 | beta-galactosidase | - | 3.2.1.23 |
68382 | beta-glucuronidase | - | 3.2.1.31 |
68382 | alpha-glucosidase | - | 3.2.1.20 |
68382 | beta-glucosidase | - | 3.2.1.21 |
68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 |
68382 | alpha-mannosidase | - | 3.2.1.24 |
68382 | alpha-fucosidase | - | 3.2.1.51 |
API zym
@ref | Control | Alkaline phosphatase | Esterase | Esterase Lipase | Lipase | Leucine arylamidase | Valine arylamidase | Cystine arylamidase | Trypsin | alpha- Chymotrypsin | Acid phosphatase | Naphthol-AS-BI-phosphohydrolase | alpha- Galactosidase | beta- Galactosidase | beta- Glucuronidase | alpha- Glucosidase | beta- Glucosidase | N-acetyl-beta- glucosaminidase | alpha- Mannosidase | alpha- Fucosidase |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
119706 | - | - | + | + | - | + | - | - | - | - | + | - | - | - | - | - | - | - | - | - |
API NH
@ref | PEN | GLU | FRU | MAL | SAC | ODC | URE | LIP | PAL | beta GAL | ProA | GGT | IND |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3508 | - | + | - | - | - | - | - | - | - | - | + | + | - |
48390 | - | + | - | - | - | - | - | - | - | - | + | - | - |
3508 | + | - | - | - | - | - | - | - | - | + | - | - | - |
3508 | + | - | - | - | - | - | - | - | - | + | - | - | - |
3508 | + | - | - | - | - | - | - | - | - | + | - | - | - |
3508 | + | - | - | - | - | - | - | - | - | + | - | - | - |
3508 | + | - | - | - | - | - | - | - | - | + | - | - | - |
3508 | - | + | +/- | - | - | - | - | - | - | - | + | - | - |
3508 | - | + | - | - | - | - | - | - | - | - | + | - | - |
3508 | - | + | - | - | - | - | - | - | - | - | + | - | - |
3508 | - | + | - | - | - | - | - | - | - | - | + | - | - |
3508 | - | + | - | - | - | - | - | - | - | - | + | - | - |
3508 | - | + | - | - | - | - | - | - | - | - | + | - | - |
3508 | - | + | - | - | - | - | - | - | - | - | + | - | - |
Isolation, sampling and environmental information
taxonmaps
- @ref: 69479
- File name: preview.99_52.png
- url: https://microbeatlas.org/index.html?action=taxon&taxon_id=90_15355;96_42;97_44;98_48;99_52&stattab=map
- Last taxonomy: Neisseria gonorrhoeae subclade
- 16S sequence: GU395613
- Sequence Identity:
- Total samples: 3694
- soil counts: 26
- aquatic counts: 208
- animal counts: 3447
- plant counts: 13
Safety information
risk assessment
@ref | biosafety level | biosafety level comment |
---|---|---|
3508 | 2 | Risk group (German classification) |
119706 | 2 | Risk group (French classification) |
Sequence information
16S sequences
@ref | description | accession | length | database | NCBI tax ID |
---|---|---|---|---|---|
20218 | Neisseria gonorrhoeae strain ATCC 49226 16S ribosomal RNA gene, complete sequence | GU395612 | 1544 | ena | 485 |
20218 | Neisseria gonorrhoeae strain 49226mut_SPC 16S ribosomal RNA gene, complete sequence | GU395613 | 1544 | ena | 485 |
Genome sequences
@ref | description | accession | assembly level | database | NCBI tax ID |
---|---|---|---|---|---|
66792 | Neisseria gonorrhoeae ATCC 49226 | GCA_016803895 | chromosome | ncbi | 485 |
66792 | Neisseria gonorrhoeae ATCC 49226 | GCA_001997645 | scaffold | ncbi | 485 |
66792 | Neisseria gonorrhoeae strain ATCC 49226 | 485.9871 | complete | patric | 485 |
66792 | Neisseria gonorrhoeae strain ATCC 49226 | 485.877 | wgs | patric | 485 |
66792 | Neisseria gonorrhoeae strain ATCC49226 | 485.866 | wgs | patric | 485 |
66792 | Neisseria gonorrhoeae ATCC 49226 | GCA_025171215 | complete | ncbi | 485 |
66792 | Neisseria gonorrhoeae strain ATCC 49226 | 485.18004 | complete | patric | 485 |
Genome-based predictions
predictions
trait | prediction | confidence | training_data |
---|---|---|---|
spore-forming | no | 100 | no |
gram-positive | no | 98.302 | no |
anaerobic | no | 97.935 | yes |
halophile | no | 61.407 | no |
spore-forming | no | 97.653 | no |
glucose-util | yes | 64.43 | no |
aerobic | no | 93.753 | no |
thermophile | no | 98.801 | yes |
motile | no | 84.291 | no |
flagellated | no | 89.468 | no |
glucose-ferment | no | 90.579 | no |
External links
@ref: 3508
culture collection no.: DSM 9189, ATCC 49226, CCUG 26213, CDC 10.001, CIP 107031, CCM 4500, CNCTC 5194
straininfo link
- @ref: 79748
- straininfo: 42367
literature
topic | Pubmed-ID | title | authors | journal | DOI | year | mesh | topic2 |
---|---|---|---|---|---|---|---|---|
Pathogenicity | 1316371 | MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin. | Erwin ME, Jones RN, Koontz FP, Gerlach EH, Murray PR, Washington JA | J Clin Microbiol | 10.1128/jcm.30.5.1317-1319.1992 | 1992 | Anti-Infective Agents/*pharmacology, Cefdinir, Ceftizoxime/*analogs & derivatives/pharmacology, Cephalosporins/*pharmacology, Diffusion, Fleroxacin/*pharmacology, *Fluoroquinolones, Microbial Sensitivity Tests/*standards, Neisseria gonorrhoeae/*drug effects, Quality Control, Quinolones/*pharmacology | |
Pathogenicity | 1500533 | Proposed interpretive criteria and quality control parameters for testing susceptibility of Neisseria gonorrhoeae to beta-lactam-clavulanate combinations. | Fuchs PC, Barry AL, Baker CN, Murray PR, Washington JA | J Clin Microbiol | 10.1128/jcm.30.8.2191-2194.1992 | 1992 | Amoxicillin/administration & dosage, Anti-Bacterial Agents/*administration & dosage, Clavulanic Acid, Clavulanic Acids/*administration & dosage, Drug Therapy, Combination/administration & dosage, Evaluation Studies as Topic, Gonorrhea/drug therapy, Humans, Microbial Sensitivity Tests/*methods/standards, Neisseria gonorrhoeae/*drug effects/isolation & purification, Quality Control, Ticarcillin/administration & dosage | Enzymology |
Pathogenicity | 1572960 | Proposed interpretive criteria and quality control parameters for ofloxacin susceptibility testing of Neisseria gonorrhoeae. | Fuchs PC, Barry AL, Baker C, Murray PR, Washington JA | J Clin Microbiol | 10.1128/jcm.30.4.1024-1026.1992 | 1992 | Drug Resistance, Microbial, Evaluation Studies as Topic, Humans, Microbial Sensitivity Tests/*methods/standards, Neisseria gonorrhoeae/*drug effects/isolation & purification, Ofloxacin/*pharmacology, Quality Control | Enzymology |
Pathogenicity | 1572967 | Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacin. | Barry AL, Cohen MA, Sesnie JC, Fuchs PC, Washington JA, Murray PR, Baker C | J Clin Microbiol | 10.1128/jcm.30.4.813-816.1992 | 1992 | Enoxacin/*pharmacology, Evaluation Studies as Topic, Gonorrhea/drug therapy/microbiology, Humans, Microbial Sensitivity Tests/*standards, Neisseria gonorrhoeae/*drug effects, Quality Control | |
Pathogenicity | 1939563 | Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin. | Fuchs PC, Barry AL, Baker C, Murray PR, Washington JA 2nd | J Clin Microbiol | 10.1128/jcm.29.10.2111-2114.1991 | 1991 | Ciprofloxacin/*pharmacology, Drug Resistance, Microbial, Gonorrhea/drug therapy, Humans, In Vitro Techniques, Microbial Sensitivity Tests/*standards, Neisseria gonorrhoeae/*drug effects/isolation & purification, Quality Control, Staphylococcus aureus/drug effects | Enzymology |
Cultivation | 2531756 | Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline. | Jones RN, Gavan TL, Thornsberry C, Fuchs PC, Gerlach EH, Knapp JS, Murray P, Washington JA 2nd | J Clin Microbiol | 10.1128/jcm.27.12.2758-2766.1989 | 1989 | Ceftriaxone/*pharmacology, Culture Media, Microbial Sensitivity Tests/standards, Neisseria gonorrhoeae/*drug effects, Penicillins/*pharmacology, Quality Control, Spectinomycin/*pharmacology, Surveys and Questionnaires, Tetracycline/*pharmacology | Pathogenicity |
Pathogenicity | 7956017 | Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study Group. | Bale MJ, Jones RN, Erwin ME | Diagn Microbiol Infect Dis | 10.1016/0732-8893(94)90054-x | 1994 | Anti-Bacterial Agents/*pharmacology, Anti-Infective Agents/*pharmacology, Bacteria/drug effects, Ceftizoxime/analogs & derivatives/pharmacology, *Fluoroquinolones, *Levofloxacin, Microbial Sensitivity Tests/*standards, Ofloxacin/*pharmacology, Piperazines/pharmacology, Quality Control, Quinolones/pharmacology, Reference Values, Spiro Compounds/pharmacology, Thienamycins/pharmacology | |
Pathogenicity | 8408559 | Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters. | Barry AL, Fuchs PC, Allen SD, Jorgensen JH, Tenover FC, Murray PR, Hardy DJ, Baker CN | J Clin Microbiol | 10.1128/jcm.31.9.2375-2380.1993 | 1993 | Anti-Infective Agents/*pharmacology, *Fluoroquinolones, Haemophilus influenzae/*drug effects, *Levofloxacin, Microbial Sensitivity Tests/*standards, Neisseria gonorrhoeae/*drug effects, Ofloxacin/*pharmacology, Quality Control, Quinolones/*pharmacology | |
Pathogenicity | 8408586 | Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group. | Bale MJ, Jones RN | J Clin Microbiol | 10.1128/jcm.31.9.2538-2540.1993 | 1993 | Anti-Infective Agents/*pharmacology, Cefdinir, Cefepime, Cefmetazole/pharmacology, Ceftizoxime/analogs & derivatives/pharmacology, Cephalosporins/*pharmacology, *Fluoroquinolones, Humans, Microbial Sensitivity Tests/*standards, Quality Control, Quinolones/*pharmacology | |
Pathogenicity | 8647755 | Tentative interpretive criteria and quality control parameters for in-vitro susceptibility testing of Neisseria gonorrhoeae to two fluoroquinolones (PD 131628 and grepafloxacin (OPC 17116)). | Sewell DL, Barry AL, Allen SD, Fuchs PC, Murray PR, Tenover FC | J Antimicrob Chemother | 10.1093/jac/37.1.139 | 1996 | Anti-Infective Agents/*pharmacology, *Fluoroquinolones, Humans, Microbial Sensitivity Tests/standards, Naphthyridines/*pharmacology, Neisseria gonorrhoeae/*drug effects, Piperazines/*pharmacology, Quality Control, Quinolones/*pharmacology | |
Pathogenicity | 9147914 | Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Results from multicenter trials. | Worth S, Erwin ME, Jones RN | Diagn Microbiol Infect Dis | 10.1016/0732-8893(95)00276-6 | 1996 | Acetamides/pharmacology, Amoxicillin/pharmacology, Amoxicillin-Potassium Clavulanate Combination, *Anti-Infective Agents, Azithromycin/pharmacology, Clavulanic Acids/pharmacology, *Fluoroquinolones, Humans, Linezolid, Microbial Sensitivity Tests/*standards, Naphthyridines/pharmacology, Oxazoles/pharmacology, *Oxazolidinones, Penicillanic Acid/analogs & derivatives/pharmacology, Piperacillin/pharmacology, Piperacillin, Tazobactam Drug Combination, Quality Control, Roxithromycin/pharmacology, Ticarcillin/pharmacology | |
Pathogenicity | 10887570 | [Antimicrobial susceptibility of Neisseria gonorrhoeae strains determined by disk diffusion]. | Llanes Caballero R, Acosta Giraldo JC, Sosa Puente J, Guzman Hernandez D, Gutierrez Gonzalez O, Llop Hernandez A | Rev Cubana Med Trop | 1999 | Bacteriological Techniques, Diffusion, Microbial Sensitivity Tests, Neisseria gonorrhoeae/*drug effects | ||
Pathogenicity | 10904193 | Development of gemifloxacin in vitro susceptibility test methods for gonococci including quality control guidelines. The Quality Control Study Group. | Jones RN, Erwin ME | Diagn Microbiol Infect Dis | 10.1016/s0732-8893(00)00139-5 | 2000 | Anti-Infective Agents/*pharmacology, Ciprofloxacin/pharmacology, Colony Count, Microbial, *Fluoroquinolones, Gemifloxacin, Microbial Sensitivity Tests/methods, Naphthyridines/*pharmacology, Neisseria gonorrhoeae/*drug effects, Quality Control, Reference Standards, Reproducibility of Results | |
Phylogeny | 15950072 | Evaluation of the BIOCEN GC agar medium base in antimicrobial susceptibility testing of Neisseria gonorrhoeae. | Llanes R, Dominguez C, Prat A, Rodriguez C, Valdes EA, Gutierrez O, Guzman D | Arch Med Res | 10.1016/j.arcmed.2005.03.011 | 2005 | Agar/*chemistry, Anti-Bacterial Agents/pharmacology, Anti-Infective Agents/*pharmacology, *Bacteriological Techniques, Cuba, *Drug Resistance, Microbial, *Microbial Sensitivity Tests, Neisseria gonorrhoeae/*metabolism, Reproducibility of Results, Species Specificity | Metabolism |
Pathogenicity | 16410969 | Studies on antimicrobial activity, in vitro, of Physalis angulata L. (Solanaceae) fraction and physalin B bringing out the importance of assay determination. | Silva MT, Simas SM, Batista TG, Cardarelli P, Tomassini TC | Mem Inst Oswaldo Cruz | 10.1590/s0074-02762005000700018 | 2006 | Agar, Anti-Bacterial Agents/*therapeutic use, Candida albicans/*drug effects, Culture Media, Drug Evaluation, Preclinical, Gram-Negative Bacteria/*drug effects, Gram-Positive Bacteria/*drug effects, Lactones/*therapeutic use, Microbial Sensitivity Tests/methods, *Physalis, Plant Extracts/pharmacology, Secosteroids, Steroids/*therapeutic use | Cultivation |
Cultivation | 17494717 | Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control. | Brown SD, Traczewski MM | J Clin Microbiol | 10.1128/JCM.02351-06 | 2007 | Anti-Bacterial Agents/*pharmacology, Bacteria/*drug effects, Culture Media, Drug Resistance, Bacterial, Microbial Sensitivity Tests, Minocycline/*analogs & derivatives/pharmacology, Quality Control, Tetracycline/*pharmacology, Tigecycline | Pathogenicity |
Enzymology | 19429310 | In vitro antigonococcal activity of Coscinium fenestratum stem extract. | Chomnawang MT, Trinapakul C, Gritsanapan W | J Ethnopharmacol | 10.1016/j.jep.2009.01.036 | 2009 | Animals, Anti-Bacterial Agents/isolation & purification/*pharmacology/therapeutic use, Berberine/isolation & purification/*pharmacology/therapeutic use, Gonorrhea/*drug therapy/microbiology, Magnoliopsida/*chemistry, Medicine, East Asian Traditional, Medicine, Traditional, Menispermaceae/chemistry, Mice, Microbial Sensitivity Tests, Neisseria gonorrhoeae/*drug effects, Phytotherapy, Plant Extracts/chemistry/*pharmacology/therapeutic use, Plant Stems, Plants, Medicinal | Phylogeny |
Pathogenicity | 19460783 | Evaluation of the mutant selection window for fluoroquinolones against Neisseria gonorrhoeae. | Allen GP, Hankins CD | J Antimicrob Chemother | 10.1093/jac/dkp172 | 2009 | Anti-Bacterial Agents/*pharmacology, Aza Compounds/pharmacology, Ciprofloxacin/pharmacology, *Drug Resistance, Bacterial, Fluoroquinolones/*pharmacology, Levofloxacin, Microbial Sensitivity Tests, Moxifloxacin, *Mutation, Neisseria gonorrhoeae/*drug effects, Ofloxacin/pharmacology, Quinolines/pharmacology, *Selection, Genetic | |
Pathogenicity | 21844727 | Resistance to azithromycin of Neisseria gonorrhoeae isolates from 2 cities in China. | Yuan LF, Yin YP, Dai XQ, Pearline RV, Xiang Z, Unemo M, Chen XS | Sex Transm Dis | 10.1097/OLQ.0b013e318219cdb5 | 2011 | Anti-Bacterial Agents/pharmacology, Azithromycin/*pharmacology, Ceftriaxone/pharmacology, China/epidemiology, Ciprofloxacin/pharmacology, Drug Resistance, Bacterial/drug effects/genetics, Female, Gonorrhea/drug therapy/epidemiology/*microbiology, Humans, Microbial Sensitivity Tests, Molecular Epidemiology, Multilocus Sequence Typing, Neisseria gonorrhoeae/*drug effects/genetics/isolation & purification, Spectinomycin/pharmacology, Tetracycline/pharmacology, Urban Population/statistics & numerical data | Enzymology |
21941568 | Increasing Trend of Resistance to Penicillin, Tetracycline, and Fluoroquinolone Resistance in Neisseria gonorrhoeae from Pakistan (1992-2009). | Jabeen K, Nizamuddin S, Irfan S, Khan E, Malik F, Zafar A | J Trop Med | 10.1155/2011/960501 | 2011 | |||
Pathogenicity | 23705013 | Non-cytotoxic nanomaterials enhance antimicrobial activities of cefmetazole against multidrug-resistant Neisseria gonorrhoeae. | Li LH, Yen MY, Ho CC, Wu P, Wang CC, Maurya PK, Chen PS, Chen W, Hsieh WY, Chen HW | PLoS One | 10.1371/journal.pone.0064794 | 2013 | Anti-Infective Agents/*pharmacology, Cefmetazole/*pharmacology, Cell Death/drug effects, Cell Line, Drug Carriers/chemistry, Drug Resistance, Multiple, Bacterial/*drug effects, Epithelial Cells/cytology/drug effects, Fibroblasts/cytology/drug effects, Humans, Ions, Metal Nanoparticles/chemistry/toxicity/ultrastructure, Microbial Sensitivity Tests, Models, Biological, Nanostructures/chemistry/*toxicity/ultrastructure, Neisseria gonorrhoeae/*drug effects/isolation & purification, Particle Size, Silver/pharmacology | Enzymology |
Pathogenicity | 24207077 | Coupling electrochemical response of a DNA biosensor with PCR for Neisseria gonorrhoeae detection. | Verma R, Sood S, Singh R, Sumana G, Bala M, Sharma VK, Samantaray JC, Pandey RM, Malhotra BD | Diagn Microbiol Infect Dis | 10.1016/j.diagmicrobio.2013.09.010 | 2013 | Adolescent, Adult, Biosensing Techniques/*methods, Diagnostic Tests, Routine/*methods, Early Diagnosis, Electrochemical Techniques/*methods, Female, Gonorrhea/*diagnosis, Humans, Male, Middle Aged, Neisseria gonorrhoeae/genetics/*isolation & purification, Polymerase Chain Reaction/*methods, Predictive Value of Tests, Sensitivity and Specificity, Young Adult | Enzymology |
Pathogenicity | 25547354 | In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates. | Hauser C, Hirzberger L, Unemo M, Furrer H, Endimiani A | Antimicrob Agents Chemother | 10.1128/AAC.04536-14 | 2014 | Anti-Bacterial Agents/*pharmacology, Azithromycin/*pharmacology, Ceftriaxone/*pharmacology, Drug Therapy, Combination/methods, Fosfomycin/*pharmacology, Gonorrhea/drug therapy/microbiology, Humans, Microbial Sensitivity Tests/methods, Neisseria gonorrhoeae/*drug effects | |
Pathogenicity | 26378286 | Determination of Disk Diffusion and MIC Quality Control Guidelines for Solithromycin, a Novel Fluoroketolide Antibacterial, against Neisseria gonorrhoeae. | Riedel S, Ross JE, Farrell DJ, Flamm RK, Jones RN | J Clin Microbiol | 10.1128/JCM.02250-15 | 2015 | Anti-Bacterial Agents/*pharmacology, Humans, Macrolides/*pharmacology, Microbial Sensitivity Tests/*standards, Neisseria gonorrhoeae/*drug effects, Quality Control, Triazoles/*pharmacology | |
Pathogenicity | 26603424 | In vitro potency and combination testing of antimicrobial agents against Neisseria gonorrhoeae. | Bharat A, Martin I, Zhanel GG, Mulvey MR | J Infect Chemother | 10.1016/j.jiac.2015.10.002 | 2015 | Anti-Infective Agents/*pharmacology, *Drug Resistance, Bacterial, *Drug Synergism, Drug Therapy, Combination, Gonorrhea/microbiology, Humans, Microbial Sensitivity Tests/*methods, Neisseria gonorrhoeae/*drug effects | |
Pathogenicity | 27161642 | Multicenter Investigation of Gepotidacin (GSK2140944) Agar Dilution Quality Control Determinations for Neisseria gonorrhoeae ATCC 49226. | Jones RN, Fedler KA, Scangarella-Oman NE, Ross JE, Flamm RK | Antimicrob Agents Chemother | 10.1128/AAC.00527-16 | 2016 | Acenaphthenes/*pharmacology, Anti-Bacterial Agents/*pharmacology, Gonorrhea/*microbiology, Heterocyclic Compounds, 3-Ring/*pharmacology, Microbial Sensitivity Tests, Neisseria gonorrhoeae/*drug effects, Topoisomerase Inhibitors/*pharmacology | |
Genetics | 27449234 | Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan. | Jabeen K, Bhawan Mal P, Khan E, Chandio S, Jacobsson S, Unemo M | BMC Infect Dis | 10.1186/s12879-016-1673-1 | 2016 | Adolescent, Adult, Anti-Bacterial Agents/*pharmacology, Child, Child, Preschool, DNA, Bacterial/analysis, *Drug Resistance, Bacterial, Female, *Genotype, Genotyping Techniques, Gonorrhea/diagnosis/epidemiology/*microbiology, Humans, Infant, Male, Microbial Sensitivity Tests, Middle Aged, Molecular Epidemiology, Neisseria gonorrhoeae/*drug effects/*genetics/isolation & purification, Pakistan/epidemiology, Prevalence, Young Adult | Pathogenicity |
Cultivation | 31315953 | Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor Zoliflodacin. | Miller AA, Traczewski MM, Huband MD, Bradford PA, Mueller JP | J Clin Microbiol | 10.1128/JCM.00567-19 | 2019 | Anti-Bacterial Agents/*pharmacology, Barbiturates/*pharmacology, Culture Media, Enzyme Inhibitors/*pharmacology, Gram-Negative Bacteria/*drug effects, Gram-Positive Bacteria/*drug effects, Isoxazoles, Microbial Sensitivity Tests/*methods/*standards, Morpholines, Oxazolidinones, Quality Control, Spiro Compounds/*pharmacology | Pathogenicity |
Metabolism | 32140142 | Comparative Proteomics of Extended-Spectrum Cephalosporin-Resistant Neisseria gonorrhoeae Isolates Demonstrates Altered Protein Synthesis, Metabolism, Substance Transport, and Membrane Permeability. | Diao N, Yan G, Yang Y, Dong Y, Wang Y, Gu W | Front Microbiol | 10.3389/fmicb.2020.00169 | 2020 | ||
Pathogenicity | 32830243 | Octenidine/carbenicillin GUMBOS as potential treatment for oropharyngeal gonorrhoea. | Lopez KM, Hobden JA, Warner IM | J Antimicrob Chemother | 10.1093/jac/dkaa346 | 2020 | Anti-Bacterial Agents/pharmacology/therapeutic use, Carbenicillin, *Gonorrhea/drug therapy, HeLa Cells, Humans, Imines, Neisseria gonorrhoeae, Pyridines, Salts | |
33558293 | In Vitro and In Vivo Activities of TP0480066, a Novel Topoisomerase Inhibitor, against Neisseria gonorrhoeae. | Masuko A, Takata I, Fujita K, Okumura H, Ushiyama F, Amada H, Sugiyama H | Antimicrob Agents Chemother | 10.1128/AAC.02145-20 | 2021 | Animals, Anti-Bacterial Agents/pharmacology, DNA Gyrase/genetics, DNA Topoisomerase IV/genetics, Drug Resistance, Bacterial, Fluoroquinolones, *Gonorrhea/drug therapy, Mice, Microbial Sensitivity Tests, *Neisseria gonorrhoeae | ||
Pathogenicity | 34391903 | In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae. | Allen GP, Deao KM, Hill SA, Schipelliti SM, Tran T | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2021.106417 | 2021 | Anti-Bacterial Agents/*pharmacology, Azithromycin/pharmacology, Ceftriaxone/pharmacology, Ciprofloxacin/pharmacology, Doxycycline/pharmacology, Drug Resistance, Multiple, Bacterial/*genetics, Ertapenem/pharmacology, Gentamicins/pharmacology, Gonorrhea/*drug therapy, Humans, Levofloxacin/pharmacology, Microbial Sensitivity Tests, Moxifloxacin/pharmacology, Neisseria gonorrhoeae/*drug effects/genetics | |
Pathogenicity | 36350125 | Antimicrobial Activity of Auranofin, Cannabidivarin, and Tolfenamic Acid against Multidrug-Resistant Neisseria gonorrhoeae. | Yang F, Liu J, Gu Y, Jiao R, Yan J, Gao S, Lin X, van der Veen S | Microbiol Spectr | 10.1128/spectrum.03952-22 | 2022 |
Reference
@id | authors | catalogue | doi/url | title | journal | pubmed |
---|---|---|---|---|---|---|
3508 | Curators of the DSMZ | Leibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 9189) | https://www.dsmz.de/collection/catalogue/details/culture/DSM-9189 | |||
20215 | Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M. | 10.1099/ijsem.0.004332 | List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ | |||
20218 | Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P. | 10.1016/j.syapm.2013.11.002 | StrainInfo introduces electronic passports for microorganisms. | Syst Appl Microbiol. 37: 42-50 2014 | 24321274 | |
36023 | Curators of the CIP | https://brclims.pasteur.fr/brcWeb/souche/detail/1/19227 | ||||
48390 | Curators of the CCUG | Culture Collection University of Gothenburg (CCUG) (CCUG 26213) | https://www.ccug.se/strain?id=26213 | |||
66792 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann | https://diaspora-project.de/progress.html#genomes | Automatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) | |||
68377 | Automatically annotated from API NH | |||||
68382 | Automatically annotated from API zym | |||||
69479 | João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich. | https://microbeatlas.org/ | MicrobeAtlas 1.0 beta | |||
69480 | Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmann | https://diaspora-project.de/progress.html#genomes | Predictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information) | |||
69481 | Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch | 10.21203/rs.3.rs-2527258/v1 | Predictions based on the model GenomeNet Sporulation v. 1 | |||
79748 | Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J. | 10.60712/SI-ID42367.1 | StrainInfo: A central database for resolving microbial strain identifiers | |||
119706 | Curators of the CIP | Collection of Institut Pasteur (CIP 107031) | https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%20107031 |